Skip to main content
. 2009 Feb;174(2):638–646. doi: 10.2353/ajpath.2009.080463

Figure 4.

Figure 4

Production of angiogenic CXC chemokines CXCL5, and CXCL8 by A549 (A) or Calu 6 (B) cells in the presence of antibody to CD74 (aCD74) or control (IgG), antibody to MIF (aMIF) or control (IgY), and ISO-1 (MIF inhibitor) or control (DMSO). A: P < 0.02 for CXCL8 and P < 0.004 for CXCL5. B: P < 0.05 for CXCL5 and P < 0.01 for CXCL8.